A carregar...
Timing of monoclonal antibody for seasonal RSV prophylaxis in the United Kingdom
Respiratory syncytial virus (RSV) infection produces more severe disease and increased hospitalization rates in high-risk babies. The monoclonal antibody palivizumab offers protection against complications, and the first of five monthly doses should be administered before the onset of community RSV...
Na minha lista:
Main Authors: | , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Cambridge University Press
2007
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2870551/ https://ncbi.nlm.nih.gov/pubmed/16753078 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/S0950268806006601 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|